Taken together these results show that CD34+DNAMbright PBMC isolated from patients with residual chronic inflammation and successfully treated HIV infection display unique phenotypic features and can generate in vitro both NK and T cells with peculiar, previously undescribed, characteristics. This evidence concerns the gene CD34 and HIV infectious disease.